Literature DB >> 29553916

100 years since the 1918 influenza pandemic.

Susanna Esposito1.   

Abstract

Mesh:

Year:  2018        PMID: 29553916      PMCID: PMC5861796          DOI: 10.1080/21645515.2018.1446591

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  37 in total

1.  Beyond the verbal: Pregnant women's preferences for receiving influenza and Tdap vaccine information from their obstetric care providers.

Authors:  Mallory Ellingson; Allison T Chamberlain
Journal:  Hum Vaccin Immunother       Date:  2018-02-12       Impact factor: 3.452

2.  Pandemic influenza 1918.

Authors:  N R Grist
Journal:  Br Med J       Date:  1979 Dec 22-29

Review 3.  Influenza vaccination in the elderly.

Authors:  Jan Smetana; Roman Chlibek; Jana Shaw; Miroslav Splino; Roman Prymula
Journal:  Hum Vaccin Immunother       Date:  2017-08-04       Impact factor: 3.452

4.  The safety of influenza vaccine in clinically cured leprosy patients in China.

Authors:  Yi Zheng; Li Chen; Jie Zou; Zheng-Gang Zhu; Li Zhu; Jing Wan; Quan Hu
Journal:  Hum Vaccin Immunother       Date:  2017-12-14       Impact factor: 3.452

5.  Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults.

Authors:  Goran Stevanovic; Lidija Lavadinovic; Svetlana Filipovic Vignjevic; Renée Holt; Katarina Ilic; Francesco Berlanda Scorza; Erin Sparrow; Vera Stoiljkovic; Guido Torelli; Tamra Madenwald; Muriel Socquet; Aleksandra Barac; Yordanka Ilieva-Borisova; Mijomir Pelemis; Jorge Flores
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

6.  Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18-60 years of age in the Republic of Korea.

Authors:  Won Suk Choi; Ji Yun Noh; Jacob Lee; Jun Yong Choi; Jin-Soo Lee; Moo Soo Kim; Hee Soo Kim; Joon Bang; Nathalie Lavis; Woo Joo Kim
Journal:  Hum Vaccin Immunother       Date:  2017-11-17       Impact factor: 3.452

7.  Influenza vaccine effectiveness among high-risk groups: A systematic literature review and meta-analysis of case-control and cohort studies.

Authors:  Vincenzo Restivo; Claudio Costantino; Stefania Bono; Marialuisa Maniglia; Valentina Marchese; Gianmarco Ventura; Alessandra Casuccio; Fabio Tramuto; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2017-06-16       Impact factor: 3.452

Review 8.  Influenza vaccines: Evaluation of the safety profile.

Authors:  Claudia Maria Trombetta; Elena Gianchecchi; Emanuele Montomoli
Journal:  Hum Vaccin Immunother       Date:  2018-01-30       Impact factor: 3.452

Review 9.  The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?

Authors:  Brian J Ward; Stephane Pillet; Nathalie Charland; Sonia Trepanier; Julie Couillard; Nathalie Landry
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452

Review 10.  Influenza immunization policies: Which could be the main reasons for differences among countries?

Authors:  Nicola Principi; Barbara Camilloni; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2017-12-21       Impact factor: 3.452

View more
  3 in total

1.  Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2.

Authors:  Peiyang Ding; Qianyue Jin; Xinxin Chen; Suzhen Yang; Junqing Guo; Guangxu Xing; Ruiguang Deng; Aiping Wang; Gaiping Zhang
Journal:  Int J Nanomedicine       Date:  2019-09-16

Review 2.  Vaccination against Paediatric Respiratory Pathogens.

Authors:  Sonia Bianchini; Alberto Argentiero; Barbara Camilloni; Ettore Silvestri; Anna Alunno; Susanna Esposito
Journal:  Vaccines (Basel)       Date:  2019-11-01

3.  Cellular 5'-3' mRNA Exoribonuclease XRN1 Inhibits Interferon Beta Activation and Facilitates Influenza A Virus Replication.

Authors:  Yen-Chin Liu; Bobo Wing-Yee Mok; Pui Wang; Rei-Lin Kuo; Honglin Chen; Shin-Ru Shih
Journal:  mBio       Date:  2021-07-27       Impact factor: 7.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.